Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease
Background/Aims To evaluate the effectiveness and safety of direct acting antivirals (DAAs) available in chronic kidney disease (CKD) patients with hepatitis C virus (HCV) infection in Korea. Methods In a retrospective, multicenter cohort study, 362 patients were enrolled from 2015 to 2019. The effe...
Main Authors: | Ji Eun Ryu, Myeong Jun Song, Seok-Hwan Kim, Jung Hyun Kwon, Sun Hong Yoo, Soon Woo Nam, Hee Chul Nam, Hee Yeon Kim, Chang Wook Kim, Hyun Yang, Si Hyun Bae, Do Seon Song, U Im Chang, Jin Mo Yang, Sung Won Lee, Hae Lim Lee, Soon Kyu Lee, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Association of Internal Medicine
2022-09-01
|
Series: | The Korean Journal of Internal Medicine |
Subjects: | |
Online Access: | http://kjim.org/upload/pdf/kjim-2021-486.pdf |
Similar Items
-
Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study
by: Soon Kyu Lee, et al.
Published: (2022-11-01) -
The care cascade for hepatitis C virus and prognosis of chronic hepatitis C patients treated with antiviral agents in a tertiary hospital
by: Sung Hwan Yoo, et al.
Published: (2023-04-01) -
Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study
by: Ji Won Han, et al.
Published: (2024-02-01) -
Clinical Characteristics of Patients with Adrenal Insufficiency in a General Hospital
by: Ye Yeon Lee, et al.
Published: (2017-02-01) -
The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2
by: Sung Yong Han, et al.
Published: (2021-05-01)